Results 231 to 240 of about 41,188 (289)

Clinical Implications of Plasma-Derived Extracellular Vesicles in Myeloproliferative Neoplasms: Unveiling Inflammatory Potential and Biomarkers for Cancer Treatment [PDF]

Ghazal Narimanfar, Dorian Forte, Roberto Maria Pellegrino, Francesca Perut, Filippo Maltoni, Martina Barone, Alessia Brancolini, Filippo Branzanti, Vincenzo Pucci, Elisabetta Lugli, Alessia Tieghi, Carla Emiliani, Johannes Grillari, Pier Luigi Zinzani, Francesca Palandri, Lucia Catani   +15 more
openalex   +1 more source

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms [PDF]

, 2009
Claire Hidalgo-Curtis, Jane F. Apperley, Anthony Stark, Michael Jeng, Jason Gotlib, Andrew Chase, Nicholas C.P. Cross, Francis Grand   +7 more
openalex   +1 more source

Arachidonic acid promotes myeloid differentiation of splenic CD45- Ter119+ cells in myeloproliferative neoplasm. [PDF]

J Cancer
Zhang L, Yang Y, Yu X, Li G, Zhang P, Ren X, Luo S, Li L, Munyurangabo G, Jia Y, Song L, He A, Kong G.   +12 more
europepmc   +1 more source

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort study. [PDF]

Br J Haematol
Batyrbekova N, Hultcrantz M, Ravn Landtblom A, Szulkin R, Dickman PW, Andersson TM, Syriopoulou E.   +6 more
europepmc   +1 more source

Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm

HemaSphere, 2018
Steffen Koschmieder, Nicolas Chatain
doaj   +1 more source

Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm. [PDF]

Cancer Med
Yoon H, Lee D, Song S, Koo B, Park J, Kim TK, Kim S, Kim S, Hong J, Byun JM, Shin DY, Kim I, Koh Y, Yoon SS.   +13 more
europepmc   +1 more source

Latent JAK2 V617F-Positive Myeloproliferative Neoplasm With Normal Blood Counts and Recurrent Splanchnic Vein Thrombosis in a Young Woman. [PDF]

Cureus
Thida AM, Luhrs C, Baral A, Zhonghua L, Brown J.   +4 more
europepmc   +1 more source

TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis. [PDF]

Eur J Haematol
Chen D, Cantu M, Siddon A, Weinberg OK.
europepmc   +1 more source

Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm. [PDF]

Cell Commun Signal
Naseer S, Singh A, Shrivastva S, Singh RK, Chowdhury S, Dey CS, Roy A.   +6 more
europepmc   +1 more source